journal article·2018-07

Radiolabeled polyoxometalate clusters: Kidney dysfunction evaluation and tumor diagnosis by positron emission tomography imaging

Dalong Ni, Dawei Jiang, Hyung-Jun Im, Hector F. Valdovinos, Bo Yu, Shreya Goel, Todd E. Barnhart, Peng Huang, Weibo Cai

Biomaterials· Volume 171
Publisher page

Abstract

Radiolabeled nanoprobes for positron emission tomography (PET) imaging has received special attention over the past decade, allowing for sensitive, non-invasive, and quantitative detection of different diseases. The rapidly renal clearable nanomaterials normally suffer from a low accumulation in the tumor through the enhanced permeability and retention (EPR) effect due to the rapidly reduced concentration in the blood circulation after renal clearance. It is highly important to design radiolabeled nanomaterials which can meet the balance between the rapid renal clearance and strong EPR effect within a suitable timescale. Herein, renal clearable polyoxometalate (POM) clusters of ultra-small size (∼1 nm in diameter) were readily radiolabeled with the oxophilic 89Zr to obtain 89Zr-POM clusters, which may allow for efficient staging of kidney dysfunction in a murine model of unilateral ureteral obstruction (UUO). Furthermore, the as-synthesized clusters can accumulate in the tumor through EPR effect and self-assemble into larger nanostructures in the acidic tumor microenvironment for enhanced tumor accumulation, offering an excellent balance between renal clearance and EPR effect.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lanthanide and Transition Metal Complexes · Metal-Organic Frameworks: Synthesis and Applications · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (61)

Show source-provided references
1. Systematic identification of novel protein domain families associated with nuclear functions10.1101/gr.203201 ↗
2. Positron emission tomography provides molecular imaging of biological processes10.1073/pnas.97.16.9226 ↗
3. In vivo fate tracking of degradable nanoparticles for lung gene transfer using PET and Cerenkov imaging10.1016/j.biomaterials.2016.04.040 ↗
4. Molecular imaging with PET10.1021/cr0782426 ↗
5. Utilizing the power of Cerenkov light with nanotechnology10.1038/nnano.2016.301 ↗
6. Positron emission tomography and nanotechnology: a dynamic duo for cancer theranostics10.1016/j.addr.2016.08.001 ↗
7. Intrinsically radiolabeled nanoparticles: an emerging paradigm10.1002/smll.201401048 ↗
8. Radiolabeled nanoparticles for multimodality tumor imaging10.7150/thno.7341 ↗
9. 68Ga-labeled gold glyconanoparticles for exploring blood-brain barrier permeability: preparation, biodistribution studies, and improved brain uptake via neuropeptide conjugation10.1021/ja411096m ↗
10. Copper-64-alloyed gold nanoparticles for cancer imaging: improved radiolabel stability and diagnostic accuracy10.1002/anie.201308494 ↗
11. Mouse positron emission tomography study of the biodistribution of gold nanoparticles with different surface coatings using embedded Copper-6410.1021/acsnano.6b03144 ↗
12. Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy10.1021/nn502950t ↗
13. PET and NIR optical imaging using self-illuminating (64)Cu-doped chelator-free gold nanoclusters10.1016/j.biomaterials.2014.08.038 ↗
14. Stable radiolabeling of sulfur-functionalized silica nanoparticles with Copper-6410.1021/acs.nanolett.6b02161 ↗
15. Silica nanoparticles as substrates for chelator-free labeling of oxophilic radioisotopes10.1021/nl503522y ↗
16. In vivo integrity and biological fate of chelator-free zirconium-89-labeled mesoporous silica nanoparticles10.1021/acsnano.5b00526 ↗
17. Radiolabeling silica-based nanoparticles via coordination chemistry: basic principles, strategies, and applications10.1021/acs.accounts.7b00635 ↗
18. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes10.1016/j.biomaterials.2012.02.060 ↗
19. Synthesis of 64Cu(II)-bis(dithiocarbamatebisphosphonate) and its conjugation with superparamagnetic iron oxide nanoparticles: in vivo evaluation as dual-modality PET-MRI agent10.1002/anie.201007894 ↗
20. Intrinsically germanium-69-labeled iron oxide nanoparticles: synthesis and in-vivo dual-modality PET/MR imaging10.1002/adma.201401372 ↗
21. Chelator-free synthesis of a dual-modality PET/MRI agent10.1002/anie.201306306 ↗
22. Aluminium hydroxide stabilised MnFe2O4 and Fe3O4 nanoparticles as dual-modality contrasts agent for MRI and PET imaging10.1016/j.biomaterials.2014.04.004 ↗
23. Cu2+-labeled, SPION loaded porous silica nanoparticles for cell labeling and multifunctional imaging probes10.1016/j.biomaterials.2009.12.025 ↗
24. cRGD-functionalized, DOX-conjugated, and (6)(4)Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging10.1016/j.biomaterials.2011.02.006 ↗
25. PET/NIRF/MRI triple functional iron oxide nanoparticles10.1016/j.biomaterials.2010.01.010 ↗
26. 18F-labeled magnetic-upconversion nanophosphors via rare-earth cation-assistant ligand assembly10.1021/nn200298y ↗
27. Fluorine-18 labeled rare-earth nanoparticles for positron emission tomography (PET) imaging of sentinel lymph node10.1016/j.biomaterials.2011.01.011 ↗
28. Multifunctional rare-earth self-assembled nanosystem for tri-modal upconversion luminescence/fluorescence/positron emission tomography imaging10.1016/j.biomaterials.2011.07.053 ↗
29. Intrinsically copper-64-labeled organic nanoparticles as radiotracers10.1002/anie.201206939 ↗
30. Non-invasive multimodal functional imaging of the intestine with frozen micellar naphthalocyanines10.1038/nnano.2014.130 ↗
31. A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy10.1021/ja106855m ↗
32. Self-illuminating 64Cu-doped CdSe/ZnS nanocrystals for in vivo tumor imaging10.1021/ja410438n ↗
33. Post-synthesis incorporation of (6)(4)Cu in CuS nanocrystals to radiolabel photothermal probes: a feasible approach for clinics10.1021/jacs.5b07973 ↗
34. Chelator-free radiolabeling of nanographene: breaking the stereotype of chelation10.1002/anie.201610649 ↗
35. Renal clearance of quantum dots10.1038/nbt1340 ↗
36. Acute kidney injury and chronic kidney disease as interconnected syndromes10.1056/NEJMra1214243 ↗
37. Nanomedicines for renal disease: current status and future applications10.1038/nrneph.2016.156 ↗
38. Clearance pathways and tumor targeting of imaging nanoparticles10.1021/acsnano.5b01320 ↗
39. A polyoxometalate cluster paradigm with self-adaptive electronic structure for acidity/reducibility-specific photothermal conversion10.1021/jacs.6b03375 ↗
40. Noninvasive staging of kidney dysfunction enabled by renal-clearable luminescent gold nanoparticles10.1002/anie.201511148 ↗
41. Self-recognition among different polyprotic macroions during assembly processes in dilute solution10.1126/science.1201121 ↗
42. Self-assembly in aqueous solution of wheel-shaped Mo154 oxide clusters into vesicles10.1038/nature02036 ↗
43. A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals10.1038/nmat3819 ↗
44. Acid pH in tumors and its potential for therapeutic exploitation
45. A pH-activatable nanoparticle with signal-amplification capabilities for non-invasive imaging of tumour malignancy10.1038/nnano.2016.72 ↗
46. Bioresponsive polyoxometalate cluster for redox-activated photoacoustic imaging-guided photothermal cancer therapy10.1021/acs.nanolett.7b00995 ↗
47. Polyoxometalates in medicine10.1021/cr960396q ↗
48. Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis10.1038/nm1384 ↗
49. Assessment of renal function in mice with unilateral ureteral obstruction using 99mTc-MAG3 dynamic scintigraphy10.1186/1471-2369-13-168 ↗
50. Dynamic 18F-fluoride small animal PET to noninvasively assess renal function in rats10.1007/s00259-008-0878-y ↗
51. Novel functional renal imaging with 18F-FDS PET in rat models of kidney diseases
52. Gallium-68 EDTA PET/CT for renal imaging10.1053/j.semnuclmed.2016.04.002 ↗
53. Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance10.1021/ja401612x ↗
54. PEGylation and zwitterionization: pros and cons in the renal clearance and tumor targeting of near-IR-emitting gold nanoparticles10.1002/anie.201304465 ↗
55. Integrating anatomic and functional dual-mode magnetic resonance imaging: design and applicability of a bifunctional contrast agent10.1021/acsnano.6b00462 ↗
56. Ultrasmall NaGdF4 nanodots for efficient MR angiography and atherosclerotic plaque imaging10.1002/adma.201305222 ↗
57. Exploiting the enhanced permeability and retention effect for tumor targeting10.1016/j.drudis.2006.07.005 ↗
58. Dynamic positron emission tomography imaging of renal clearable gold nanoparticles10.1002/smll.201600194 ↗
59. In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles10.1021/nn403617j ↗
60. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake10.1021/ja2084338 ↗
61. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment10.1039/C1CS15233E ↗